When was Cognito Therapeutics founded?

Cognito Therapeutics was founded in 2016 and raised its 1st funding round within a year of its incorporation.

Where is Cognito Therapeutics located?

Cognito Therapeutics is headquartered in Cambridge, United States.

How many employees does Cognito Therapeutics have?

As of Sep 30, 2026, the latest employee count at Cognito Therapeutics is 70.

Is Cognito Therapeutics a funded company?

Cognito Therapeutics is a funded company, having raised a total of $420M across 5 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on 2016.

When was the latest funding round of Cognito Therapeutics?

Cognito Therapeutics' latest funding was a $***** Series C round on Mar 05, 2026, with participation from 6 investors.

Where does Cognito Therapeutics rank among its competitors?

Cognito Therapeutics ranks 1st amongst 17 active competitors, of which 6 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Cognito Therapeutics, which secured $105M in Mar, 2026.

Who are the top competitors of Cognito Therapeutics?

Cognito Therapeutics' top competitors include Grey Matter Neurosciences, NeuroEM and Sinaptica Therapeutics. Among them, Cognito Therapeutics secured the most recent funding round in March, 2026.

Cognito Therapeutics - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of a medical device for the treatment of Alzheimer's disease. The device uses gamma stimulation which helps in reactivating the immune system of the brain. It results in the reduction of amyloid plaques and tau tangles which are typical hallmarks of the disease.

Website: www.cognitotx.com/
Social
Email ID: *****@cognitotx.com
Phone Number: +1 **********

Key Metrics

Founded Year

2016

Location

Cambridge, United States

Stage

Series C

Total Funding

$420M in 5 rounds

Latest Funding Round

Series C, Mar 05, 2026, $*****

Investors

Morningside & 11 more

Ranked

1^st among 17 active competitors

Employee Count

70 as on Sep 30, 2026

Similar Companies

Grey Matter Neurosciences & 17 more

View Cognito Therapeutics' full profile

Cognito Therapeutics is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Cognito Therapeutics, Inc. CIN: 201-5088 , United States, Active	Dec 31, 2015	-	-	-

Cognito Therapeutics has raised a total funding of $420M over 5 rounds. Its first funding round was on 2016. Its latest funding round was a Series C round on Mar 05, 2026 for $*****. 6 investors participated in its latest round. Cognito Therapeutics has 12 institutional investors.

Here is the list of recent funding rounds of Cognito Therapeutics:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 05, 2026	9837286	Series C	3341715	5068572	6507051	7202377
Mar 19, 2025	9553320	Series C	2026552	9673966	5110082	7311172
Jun 18, 2024	4314901	Series B	8837409	7435930	4515974	6750355

Access funding benchmarks and valuations. Sign up today!

View details of Cognito Therapeutics's funding rounds and investors

The founders of Cognito Therapeutics are Ed Boyden and Li-Huei Tsai.

Here are the details of Cognito Therapeutics' key team members:

Ed Boyden: Co-Founder of Cognito Therapeutics.
Li-Huei Tsai: Co-Founder of Cognito Therapeutics.

View details of Cognito Therapeutics's Founder profiles and Board Members

Cognito Therapeutics' employee count trend

Cognito Therapeutics has 70 employees as of Sep 26. Here is Cognito Therapeutics's employee count trend over the years:

Employee count trend for Cognito Therapeutics

Uncover Cognito Therapeutics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Cognito Therapeutics include Grey Matter Neurosciences, NeuroEM and Sinaptica Therapeutics. Here is the list of Top 10 competitors of Cognito Therapeutics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Cognito Therapeutics 2016, Cambridge (United States), Series C	Developer of a medical device for the treatment of Alzheimer's disease	$420M	IAG Capital Partners, Morningside & 10 others	65/100
2nd	Grey Matter Neurosciences 2021, Toronto (Canada), Seed	Developer of medical devices for neurological disease treatment	$14M	Wittington Ventures, Ontario Centre of Innovation ... & 2 others	55/100
3rd	NeuroEM 2013, Tampa (United States), Series A	Developer of medical device a non-invasive treatment for cognitive decline	$9M	Bluelake, New York Angels & 1 others	50/100
4th	Sinaptica Therapeutics 2022, Cambridge (United States), Seed	Developer of personalized closed-loop neuromodulation therapy for Alzheimer’s Disease	-	Sony Innovation Fund, CABHI	45/100
5th	OptoCeutics 2018, Kongens Lyngby (Denmark), Seed	Provider of solutions for treating and diagnosing neurological disease	$2.63M	EIC Fund, Europa & 4 others	42/100
6th	Functional Neuromodulation 2010, Boston (United States), Seed	Deep Brain Stimulation of the Fornix (DBSf) technology for Alzheimer's disease treatment	$3M	Southern New Hampshire Health, Medtronic & 3 others	35/100
7th	Braingrade 2019, Wilmington (United States), Unfunded	Developer of a medical device for treatment of Alzheimer's	-	-	30/100
8th	The Brain Protection Company 2002, Paddington (Australia), Funding Raised	Developer of therapies and diagnostics solutions to manage dementia and Alzheimer’s diseases	-	Gates, M.H. Carnegie & Co	29/100
9th	YoTeCuido Alzheimer 2016, A Coruna (Spain), Unfunded	App-based platform provider for caregivers and Alzheimer's patients	-	-	26/100
10th	Lazaro Reus (Spain), Unfunded	Lazaro » Home	-	-	24/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Cognito Therapeutics's competitors? Click here to see the top ones

Cognito Therapeutics has made no investments or acquisitions yet.

Here is the latest report on Cognito Therapeutics's sector:

Free

Neurology - Sector Report

Edition: August, 2026 (73 Pages)

View all reports related to Cognito Therapeutics

Media has covered Cognito Therapeutics for a total of 8 events in the last 1 year, 4 of them have been about company updates and 2 about partnerships.